Abstract
Get full access to this article
View all access options for this article.
References
1.
Blevins
DP
,
Dadu
R
,
Hu
M
,
Baik
C
,
Balachandran
D
,
Ross
W
,
Gunn
B
,
Cabanillas
ME
et al . 2014 . Aerodigestive fistula formation as a rare side effect of antiangiogenic tyrosine kinase inhibitor therapy for thyroid cancer . Thyroid , 24 :918 –922 .
2.
Schlumberger
M
,
Tahara
M
,
Wirth
L
,
Robinson
B.
,
Brose
M
,
Elisei
R
,
Ductus
C
,
de las Heras
B
,
Zhu
J
,
Habra
M
,
Newbold
K
,
Shah
M
,
Hoff
A
,
Gianoukaki
A
,
Kiyota
N
,
Taylor
M
,
Kim
S
,
Krzyzanowska
M
,
Sherman
SI
. 2014 . A phase III, multicenter, double blind, placebo controlled trial of lenvatinib (E7080) in patients with 131I-refractory differentiated thyroid cancer (SELECT) . J Clin Oncol , 32 :5s .